[HTML][HTML] Plants metabolites: possibility of natural therapeutics against the COVID-19 pandemic
COVID-19, a disease induced by SARS-CoV-2 (Severe Acute Respiratory Syndrome
Coronavirus-2), has been the cause of a worldwide pandemic. Though extensive research …
Coronavirus-2), has been the cause of a worldwide pandemic. Though extensive research …
An exhaustive comprehension of the role of herbal medicines in Pre-and Post-COVID manifestations
SK Prajapati, A Malaiya, G Mishra, D Jain… - Journal of …, 2022 - Elsevier
Ethnopharmacological relevance The coronavirus disease (COVID-19) has relentlessly
spread all over the world even after the advent of vaccines. It demands management …
spread all over the world even after the advent of vaccines. It demands management …
[HTML][HTML] Predicted therapeutic targets for COVID-19 disease by inhibiting SARS-CoV-2 and its related receptors
N Balmeh, S Mahmoudi, N Mohammadi… - Informatics in medicine …, 2020 - Elsevier
The SARS-CoV-2 causes severe pulmonary infectious disease with an exponential spread-
ability. In the present research, we have tried to look into the molecular cause of disease …
ability. In the present research, we have tried to look into the molecular cause of disease …
[HTML][HTML] Assessing potential inhibitors of SARS-CoV-2 main protease from available drugs using free energy perturbation simulations
The main protease (Mpro) of the novel coronavirus SARS-CoV-2, which has caused the
COVID-19 pandemic, is responsible for the maturation of its key proteins. Thus, inhibiting …
COVID-19 pandemic, is responsible for the maturation of its key proteins. Thus, inhibiting …
[HTML][HTML] Synthesis, biological and computational studies of flavonoid acetamide derivatives
This study reports the synthesis and characterization of a novel class of flavonoid acetamide
derivatives (FA) of quercetin, apigenin, fisetin, kaempferol, and luteolin. Flavonoids display …
derivatives (FA) of quercetin, apigenin, fisetin, kaempferol, and luteolin. Flavonoids display …
Novel Drug Design for Treatment of COVID‐19: A Systematic Review of Preclinical Studies
Background. Since the beginning of the novel coronavirus (SARS‐CoV‐2) disease
outbreak, there has been an increasing interest in discovering potential therapeutic agents …
outbreak, there has been an increasing interest in discovering potential therapeutic agents …
[HTML][HTML] Inhibitory potentiality of secondary metabolites extracted from marine fungus target on avian influenza virus-a subtype H5N8 (Neuraminidase) and H5N1 …
Highly contagious avian influenza virus'(AIV) subtypes, including H5N1 and H5N8 are
considered as serious threats for poultry industry. Despite its severity, treatment and …
considered as serious threats for poultry industry. Despite its severity, treatment and …
Exploring the Fatty Acid Binding Pocket in the SARS-CoV-2 Spike Protein–Confirmed and Potential Ligands
L Queirós-Reis, JR Mesquita, A Brancale… - Journal of Chemical …, 2023 - ACS Publications
Severe Acute Respiratory syndrome 2 (SARS-CoV-2) is a respiratory virus responsible for
coronavirus disease 19 (COVID-19) and the still ongoing and unprecedented global …
coronavirus disease 19 (COVID-19) and the still ongoing and unprecedented global …
Molecular docking and machine learning affinity prediction of compounds identified upon softwood bark extraction to the main protease of the SARS-CoV-2 virus
M Jablonský, M Štekláč, V Majová, M Gall… - Biophysical …, 2022 - Elsevier
Molecular docking of 234 unique compounds identified in the softwood bark (W set) is
presented with a focus on their inhibition potential to the main protease of the SARS-CoV-2 …
presented with a focus on their inhibition potential to the main protease of the SARS-CoV-2 …
[HTML][HTML] Identification of potential antivirals against SARS-CoV-2 using virtual screening method
SARS-CoV-2 has triggered a major epidemic among people around the world, and it is the
newest in the sequence to become prevalent among other infectious diseases. The drug …
newest in the sequence to become prevalent among other infectious diseases. The drug …